Home

Message From The Director

Program Description
Curriculum
Program Faculty
Academic Environment
Current Students and Alumni
Houston Area
Application Procedure
Financial Information
Useful Links
Contact Us
Molecular Pathology Program Faculty Advisors
Alphabetical List


Diane L. Hickson- Bick, Ph.D., Program Director
  M. Tien Kuo, Ph.D.
Jeffrey K. Actor, Ph.D. Sue-Hwa Lin, Ph.D.

Constance Albarricin, M.D. Ph.D

Jun Lui, Ph.D.
Ralph B. Arlinghaus, Ph.D Timothy J. McDonnell, M.D., Ph.D.
L. Maximilian Buja, M.D., Dianna M. Milewicz, M.D., Ph.D.
Jiale Dai, Ph.D. Frank G. Moody, M.D.
Peter J.A. Davies, M.D., Ph.D. Steven J. Norris, Ph.D.
Madeleine Duvic, M.D. Angel Paredes, Ph.D.
Richard J. Ford, M.D., Ph.D. Sudhir Paul, Ph.D.
Kenichi Fujise, M.D. L. Scott Rodkey, Ph.D.
Peter R. C. Gascoyne, Ph.D. Jagannadha K. Sastry, Ph.D.
Yong-Jian Geng, Ph.D James K. Stoops, Ph.D.
Peng Huang, M.D., Ph.D. Henry W. Strobel, Ph.D.
Mien-Chie Hung, Ph.D. Heinrich Taegtmeyer, M.D., D.Phil.
Robert L. Hunter, M.D., Ph.D. Ba-bie Teng, Ph.D.

Chinnaswamy Jagannath, Ph.D.

Elizabeth L. Travis, Ph.D.
Tetsu Kamitani, M.D., Ph.D. Audrey Wanger, Ph.D.
Victoria Knutson, Ph.D.
Edward T.H. Yeh, M.D.
Ryuji Kobayashi, Ph.D.
Z. Hong Zhou, Ph.D

Faculty Research Interests

Molecular Pathology of Carcinogenesis

Ralph B. Arlinghaus, Ph.D.: Professor and chairman of the Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. RNA tumor viruses (retroviruses), the v-Mos oncoprotein, and the role of Bcr in Bcr-Abl positive human leukemia.

Constance Albarricin, M.D. Ph.D.: Department of Pathology at the University of Texas M. D. Anderson Cancer Center. Cancers of the breast and uterus with collaborations in esophagus, central nervous system and kidney cancers

Jiale Dai, Ph.D: Assistant Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Molecular genetics and biology of breast cancer.

Madeleine Duvic, M.D.: Professor, Department of Dermatology at the University of Texas M. D. Anderson Cancer Center. Molecular Pathogenesis of Skin Diseases

Richard J. Ford, M.D., Ph.D.: Professor, Chief; Section of Pathobiology, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Cell growth control in normal and neoplastic human B lymphocytes.

Peter R. C. Gascoyne, Ph.D.: Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Development of dielectric methods for discriminating between, and isolating, diseased cells and pathogens.

Peng Huang, M.D., Ph.D.: Associate Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Biochemical and molecular mechanisms of action of anticancer agents.

Mien-Chie Hung, Ph.D.: Chairman, Dept. of Molecular and Cellular Oncology, Director, Breast Cancer Basic Research Program at the University of Texas M. D. Anderson Cancer Center, Ruth Legett Jones Distinguished Chair Professor. Oncogenes, Tumor Suppressor Genes, Signal Transduction, and Gene Therapy.

Ryuji Kobayashi, Ph.D.: Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Method development in proteomics research; Bcr-Abl signaling in leukemia; TCL-1 function in T-cell tumorigenesis; protein S-nitrosylation.

M. Tien Kuo, Ph.D.: Felix L. Haas Professor in Basic Science Department of Molecular Pathology
Chief, Section of Eukaryotic Cell Research, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer. Evolution of drug resistance and tumor development; Targeted prodrug therapy of liver cancers; Genomic instability and evolution of drug resistance.

Sue-Hwa Lin, Ph.D.: Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Prostate cancer bone metastasis; Roles of CEACAM1 cell adhesion molecule in prostate cancer; Roles of anti-angiogenic protein 16-kDa prolactin in prostate cancer.

Timothy J. McDonnell, M.D., Ph.D.: Professor, Department of Molecular Pathology at the University of Texas M. D. Anderson Cancer Center. Molecular oncology; Molecular determinants of therapeutic response.

Elizabeth L. Travis, Ph.D.: Professor, Experimental and Radiation Oncology at the University of Texas M. D. Anderson Cancer Center. Radiation-induced fibrosis; genetic basis of tissue radiation sensitivity and fibrosis; growth factors.

Cellular and Molecular Pathology of Human Disease

Diane L. Hickson- Bick, Ph.D., Associate Professor and Program Director, Department of Pathology at The University of Texas Medical School Houston. The role of cardiolipin in the induction of apoptosis, toxic shock and the heart. Cardiac fatty acid metabolism.

L. Maximilian Buja, M.D.:Executive Vice President UT Health Science Center and Professor, Department of Pathology at The University of Texas Medical School Houston. Myocardial and vascular cell biology and pathology; calcium homeostasis; phospholipid metabolism; adrenergic mechanisms

Peter J.A. Davies, M.D., Ph.D.: Professosr, Department of Integrative Biology and Pharmacology at The University of Texas Medical School Houston.Retinoids, Cell Death, and Metabolic Diseases.

Kenichi Fujise, M.D.: Associate Professor, Brown Foundation Institute of Molecular Medicine, Center for Cardiovascular Research. Fortilin and PARISs (Apoptosis, Cell cycle regulation, Atherosclerosis, Postangioplasty Restenosis).

Yong-Jian Geng, Ph.D.: Associate Professor, Department of Medicine at The University of Texas Medical School Houston and The Texas Heart Institute. Cardiovascular gene expression; apoptosis; lipoprotein metabolism; transgenic mice; gene and cell therapy; tissue engineering .

Tetsu Kamitani, M.D., Ph.D.: Associate Professor, Department of Cardiology, University of Texas M.D. Anderson Cancer Center. Post-translational modification; regulation by ubiquitination; conjugation with ubiquitin-like protein; SUMO; NEDD8; proteolysis by proteasome; function of NUB1; ubiquitination by Ro52; ubiquitination by TRIM5.

Victoria Knutson, Ph.D.: Associate Professor, Department of Integrative Biology and Pharmacology at The University of Texas Medical School Houston. Insulin receptor; signal transduction; tyrosine kinase; breast cancer.

Dianna M. Milewicz, M.D., Ph.D.: Professor, Department of Medicine at The University of Texas Medical School Houston. Molecular Pathology of Human Genetic Disorders Altering the Elastic Fiber System.

Frank G. Moody, M.D.: Professor, Department of Medicine at The University of Texas Medical School Houston. The pathogenesis of acute pancreatitis and multiple organ failure.

Henry W. Strobel, Ph.D.: Professor, Department of Biochemistry and Molecular Biology at The University of Texas Medical School Houston. Drug metabolism; carcinogenesis; cancer chemotherapy; cytochrome P-450; neurobiology of drug action.

Heinrich Taegtmeyer, M.D., D.Phil.: Professor, Department of Medicine at The University of Texas Medical School Houston. Energy substrate metabolism; gene expression and function of the heart; heart failure and diabetes.

Ba-bie Teng, Ph.D.: Associate Professor, Brown Foundation Institute of Molecular Medicine, Research Center for Human Genetics.Gene therapy, vector development, atherosclerosis, RNA editing.

Edward T.H. Yeh, M.D.: Professor and Chairman, Department of Cardiology at the University of Texas M. D. Anderson Cancer Center.Regulation of SUMO and NEDD8 modification; Stem Cell Transplant for Cardiovascular Diseases.

The Pathogenesis and Immunological Basis of Infectious Disease

Jeffrey K. Actor, Ph.D.: Associate Professor, Department of Pathology at The University of Texas Medical School Houston. Examination of host immune responses during parasitic disease; understanding proinflammatory and regulatory cytokines during mycobacterial infections; quantitative bioluminescent RT-PCR; vaccine development.

Robert L. Hunter, M.D., Ph.D.: Professor and Chair, Department of Pathology at The University of Texas Medical School Houston. Tuberculosis.

Chinnaswamy Jagannath, Ph.D.: Associate Professor, Department of Pathology at The University of Texas Medical School Houston. The biology of Mycobacterium tuberculosis (MTB).

Steven J. Norris, Ph.D.: Professor, Department of Pathology at The University of Texas Medical School Houston. Pathogenesis and Its Relationship to the Molecular Genetics of Invasive Bacteria.

Sudhir Paul, Ph.D.: Professor, Department of Pathology at The University of Texas Medical School Houston. Evolution of catalytic activity in antibodies (Abs); Functional role of Ab catalysis in autoimmune disease; Elicitation of catalytic immunity in vaccination against cancer and microbes; Interactions of amphiphilic neuropeptides with lipids .

L. Scott Rodkey, Ph.D.: Professor, Department of Pathology at The University of Texas Medical School Houston. Antibodies, mechanism of action and function in health and disease; studies of Rh blood group antigens, structure and function; electrophoresis technology.

Jagannadha K. Sastry, Ph.D.:Professor, Department of Immunology at the University of Texas M. D. Anderson Cancer Center. HIV-AIDS; cervical cancer; vaccines; cellular immunology; synthetic peptides.

Audrey Wanger, Ph.D.: Associate Professor, Department of Pathology at The University of Texas Medical School Houston. Application of Molecular Biology to Clinical Microbiology.

The Structural Basis of Disease

Jun Lui, Ph.D.:

Angel Paredes, Ph.D.:

James K. Stoops, Ph.D.: Professor, Department of Pathology at The University of Texas Medical School Houston. Structure-function Studies of Macromolecules of Biological Interest.

 



Last Updated May 6, 2005 | Submit question and comments to: Webmaster